SABCS 2020 | Using biology to identify best outcomes

Shane Stecklein, MD, PhD, University of Kansas Medical Center, Kansas City, KS, outlines the future of breast cancer treatment and management, including using a greater of the biology of tumors to provide appropriate treatments to patients, including de-escalation to prevent unnecessary toxicity. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).